Autoantibodies against Modified Histone Peptides in SLE Patients Are Associated with Disease Activity and Lupus Nephritis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Autoantibodies against Modified Histone Peptides in SLE Patients Are Associated with Disease Activity and Lupus Nephritis
Authors
Keywords
Histones, Systemic lupus erythematosus, Lysine, Lupus nephritis, Chromatin, Apoptosis, Nephritis, Autoantibodies
Journal
PLoS One
Volume 11, Issue 10, Pages e0165373
Publisher
Public Library of Science (PLoS)
Online
2016-10-26
DOI
10.1371/journal.pone.0165373
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Circulating Apoptotic Microparticles in Systemic Lupus Erythematosus Patients Drive the Activation of Dendritic Cell Subsets and Prime Neutrophils for NETosis
- (2016) Jürgen Dieker et al. Arthritis & Rheumatology
- Acetylated histones contribute to the immunostimulatory potential of neutrophil extracellular traps in systemic lupus erythematosus
- (2014) E. Pieterse et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Review: Antinucleosome Antibodies: A Critical Reflection on Their Specificities and Diagnostic Impact
- (2014) Ole Petter Rekvig et al. Arthritis & Rheumatology
- Antibodies from patients with rheumatoid arthritis target citrullinated histone 4 contained in neutrophils extracellular traps
- (2013) Federico Pratesi et al. ANNALS OF THE RHEUMATIC DISEASES
- The fibrin-derived citrullinated peptide β60–74Cit60,72,74bears the major ACPA epitope recognised by the rheumatoid arthritis-specific anticitrullinated fibrinogen autoantibodies and anti-CCP2 antibodies
- (2013) M Cornillet et al. ANNALS OF THE RHEUMATIC DISEASES
- Baseline Predictors of Systemic Lupus Erythematosus Flares: Data From the Combined Placebo Groups in the Phase III Belimumab Trials
- (2013) Michelle A. Petri et al. ARTHRITIS AND RHEUMATISM
- A surge in anti-dsDNA titer predicts a severe lupus flare within six months
- (2013) N Pan et al. LUPUS
- Unknown
- (2013) Natalya Seredkina et al. MOLECULAR MEDICINE
- Systemic Lupus Erythematosus Patients Contain Significantly Less IgM against Mono-Methylated Lysine than Healthy Subjects
- (2013) Sha Guo et al. PLoS One
- An Integrated Peptide-Antigen Microarray on Plasmonic Gold Films for Sensitive Human Antibody Profiling
- (2013) Bo Zhang et al. PLoS One
- Low diagnostic and predictive value of anti-dsDNA antibodies in unselected patients with recent onset of rheumatic symptoms: results from a long-term follow-up Scandinavian multicentre study
- (2013) M Compagno et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Autoimmunity to isomerized histone H2B in systemic lupus erythematosus
- (2012) Hester A. Doyle et al. AUTOIMMUNITY
- Apoptosis and NET formation in the pathogenesis of SLE
- (2012) Yvette M. Bouts et al. AUTOIMMUNITY
- Simultaneous Positivity for Anti-DNA, Anti-Nucleosome and Anti-Histone Antibodies is a Marker for More Severe Lupus Nephritis
- (2012) Mansu Sui et al. JOURNAL OF CLINICAL IMMUNOLOGY
- IgG and IgM Autoantibody Differences in Discoid and Systemic Lupus Patients
- (2012) Benjamin F. Chong et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- On silico peptide microarrays for high-resolution mapping of antibody epitopes and diverse protein-protein interactions
- (2012) Jordan V Price et al. NATURE MEDICINE
- Anti-CCP antibodies: the past, the present and the future
- (2011) Walther J. van Venrooij et al. Nature Reviews Rheumatology
- Lupus Nephritis: Role of Antinucleosome Autoantibodies
- (2011) Johan van der Vlag et al. SEMINARS IN NEPHROLOGY
- Apoptosis-induced histone H3 methylation is targeted by autoantibodies in systemic lupus erythematosus
- (2010) C. C. van Bavel et al. ANNALS OF THE RHEUMATIC DISEASES
- Cracking the death code: apoptosis-related histone modifications
- (2010) J Füllgrabe et al. CELL DEATH AND DIFFERENTIATION
- Peroxynitrite-induced modification of H2A histone presents epitopes which are strongly bound by human anti-DNA autoantibodies: Role of peroxynitrite-modified-H2A in SLE induction and progression
- (2010) Kiran Dixit et al. HUMAN IMMUNOLOGY
- Identification of New Pathogenic Players in Lupus: Autoantibody-Secreting Cells Are Present in Nephritic Kidneys of (NZBxNZW)F1 Mice
- (2010) S. Lacotte et al. JOURNAL OF IMMUNOLOGY
- Lupus-derived monoclonal autoantibodies against apoptotic chromatin recognize acetylated conformational epitopes
- (2010) Casandra C. van Bavel et al. MOLECULAR IMMUNOLOGY
- The role of defective clearance of apoptotic cells in systemic autoimmunity
- (2010) Luis E. Muñoz et al. Nature Reviews Rheumatology
- Nucleic acid-associated autoantigens: Pathogenic involvement and therapeutic potential
- (2009) Markus H. Hoffmann et al. JOURNAL OF AUTOIMMUNITY
- The use of post-translationally modified peptides for detection of biomarkers of immune-mediated diseases
- (2009) Anna Maria Papini JOURNAL OF PEPTIDE SCIENCE
- Sensitivity and specificity of autoantibody tests in the differential diagnosis of lupus nephritis
- (2009) U. Heidenreich et al. LUPUS
- Apoptosis-associated acetylation on histone H2B is an epitope for lupus autoantibodies
- (2009) Casandra C. van Bavel et al. MOLECULAR IMMUNOLOGY
- The role of microparticles in the pathogenesis of rheumatic diseases
- (2009) Christian Beyer et al. Nature Reviews Rheumatology
- Antinucleosome Antibodies as a Marker of Active Proliferative Lupus Nephritis
- (2008) Cornelia Bigler et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Characterisation of cellular and humoral autoimmune responses to histone H1 and core histones in human systemic lupus erythaematosus
- (2008) G H Stummvoll et al. ANNALS OF THE RHEUMATIC DISEASES
- Anti‐histones antibodies in systemic lupus erythematosus: prevalence and frequency in neuropsychiatric lupus
- (2008) Xiao‐Yun Sun et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation